Insulet (PODD) EBIT Margin (2010 - 2026)
Insulet's (PODD) quarterly EBIT Margin came in at 16.18% in Q2 2026, down 248.0% on a YoY basis from 10.93% in Q2 2025, and up 0.92% quarter-over-quarter from 16.03% in Q1 2026.
Powered by 
Analysis
Insulet (PODD) EBIT Margin (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported EBIT Margin for 17 consecutive years, with 16.18% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBIT Margin fell 248.0% year-over-year to 16.18%; the trailing twelve-month figure through Jun 2026 stood at 16.89% (down 37.0% YoY), and the FY2025 full-year result was 17.5%, up 258.0% from the prior year.
- EBIT Margin improved to 16.18% in Q2 2026 per PODD's latest filing, from 16.03% in the prior quarter.
- Across five years, EBIT Margin topped out at 20.89% in Q4 2023 and bottomed at 8.92% in Q2 2022.
- Historically, EBIT Margin has averaged 12.25% across 5 years, with a median of 14.24% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin sank 1891 bps in 2022, then surged 1676 bps in 2023.
- Over 5 years, EBIT Margin stood at 6.36% in 2022, then jumped by 229 bps to 20.89% in 2023, then declined by 12 bps to 18.29% in 2024, then gained by 2 bps to 18.67% in 2025, then fell by 13 bps to 16.18% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 16.18%, 16.03%, and 18.67% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 19.15% |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | 16.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.18% |
| Mar 31, 2026 | 16.03% |
| Dec 31, 2025 | 18.67% |
| Sep 30, 2025 | 16.66% |
| Jun 30, 2025 | 18.66% |
| Mar 31, 2025 | 15.61% |
| Dec 31, 2024 | 18.29% |
| Sep 30, 2024 | 16.20% |
| Jun 30, 2024 | 11.16% |
| Mar 31, 2024 | 12.88% |
| Dec 31, 2023 | 20.89% |
| Sep 30, 2023 | 12.66% |
| Jun 30, 2023 | 7.84% |
| Mar 31, 2023 | 7.74% |
| Dec 31, 2022 | 6.36% |
| Sep 30, 2022 | 0.85% |
| Jun 30, 2022 | -8.92% |
| Mar 31, 2022 | 12.83% |
| Dec 31, 2021 | 16.15% |
| Sep 30, 2021 | 12.23% |